
FDA approved mepolizumab (Nucala) as an add-on maintenance therapy for the treatment of patients with severe asthma who are 12 years and older and with an eosinophilic phenotype.

FDA approved mepolizumab (Nucala) as an add-on maintenance therapy for the treatment of patients with severe asthma who are 12 years and older and with an eosinophilic phenotype.

You want to see change in the way pharmacists are treated? Change what you're doing - and start with incorrect Rxs.

Using data from various non-traditional resources, a team of epidemiologists from Boston Children’s Hospital has developed a system to predict flu-like activity up to three weeks in advance.

The U.S. Senate will conduct a bipartisan investigation into pharmaceutical drug prices following recent public and political outrage over drastic price increases for certain drugs.

Early data from a clinical study supported by the National Institutes of Health found that adults with hypertension and at least one other risk factor for heart disease were less likely to have a heart attack, stroke, or heart failure with a reduction of systolic blood pressure to 120 mm Hg.

The MDLive telehealth services available through Walgreens’ mobile application are now available to users in 25 states and promises better functionality and integration.

Maybe retail pharmacy organizations should take a look at their priorities before they find themselves at an evolutionary dead end.

How can your health system best manage shortages? Here are some key considerations.

What if the national and state pharmacy organizations combined to get their message out? And what if they linked that message to a series of national and international events?

Since they see diabetic patients so often, community pharmacists who encourage vaccination can play a major role in boosting public health.

New treatment options range from novel insulin therapies to GLP-1 agonists, DPP-4 inhibitors, SGLT-2 inhibitors, and more.

In 2012, approximately 37% of the adults in America had prediabetes, and almost 90% of them didn't realize it. The importance of intervention/education by community pharmacists cannot be overestimated.

If you are a pharmacist who deals with patients, expect to deal with gestational diabetes.

Type 2 diabetes is associated with a two- to four-fold increase in the risk of CVD. Pharmacists can monitor and manage the risk factors.

As CGM technology evolves, pharmacists can play a key role in helping patients navigate new systems coming on the market.

If you enjoy working one-on-one with patients and have an entrepreneurial spirit, this might just be for you.

"I want it and I want it NOW" is not always your best move. Especially with the pharmacist who is filling your Rx.

How to take in the Big Picture, New Pharmacy-style.

Can you say "Risperdal," boys and girls?

Medication reconciliation, inpatient care, med safety, discharge education, transitions of care, medication adherence - these are only some of the ways pharmacists can benefit the healthcare team. There are plenty more.

Drug Topics' peripatetic pharmacist-correspondent reports from FIP 2015 in Dusseldorf.

For patients with heart failure, Entresto is the first treatment available that has been shown to decrease hospitalizations and reduce the risk of cardiovascular-related death.

CMS will now offer payers enticements to increase patient med adherence under the existing MTM model. The Part D effort is specifically focused on stand-alone Part D plans.

Venous limb gangrene can occur in cancer patients, but the clinical picture and pathogenesis aren’t clear.

A Fort Lauderdale university clinic emphasizes the connection between health, wellness, and prevention.

The pros and cons of unionizing.

New Rx, generics, OTC, devices, apps, and more.

Kaiser Permanente Northwest has greatly improved physician efficiency and medication accuracy – and saved the healthcare system millions of dollars - with a pharmacist-centered medication refill program.

ISMP outlines 10 precautions to follow in methotrexate dosing and administration.

The New Hampshire Board of Medicine rejected a set of rules proposed by Gov. Maggie Hassan designed to more closely regulate doctors who prescribe opioid painkillers.